Breaks Categories: News

WednesdayNov 02, 2022 12:09 pm

NetworkNewsBreaks – Stronghold Digital Mining Inc. (NASDAQ: SDIG) Executes on Strategy to Deliver Balance Sheet, Enhance Liquidity

Stronghold (NASDAQ: SDIG) has announced (i) the extinguishment of the final approximately $2.1 million of the total of approximately $67 million of principal amount of debt outstanding with NYDIG ABL LLC (“NYDIG”) and The Provident Bank (“BankProv”) and (ii) the closing of its previously announced WhiteHawk restructuring and credit facility that resulted in $23 million of additional borrowing capacity. According to the update, the company believes these moves are important steps in Stronghold’s plan to improve profitability and liquidity and to reduce leverage despite low Bitcoin prices. “We are executing on the strategy we outlined during our second quarter earnings…

Continue Reading

WednesdayNov 02, 2022 11:54 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Doses First Patient in Global Berubicin Trial Evaluating GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has provided an update on enrollment of its ongoing trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. The company announced that the first patient in Europe has been enrolled in the study and has started receiving dosages. Eventually the company plans to have 68 sites opened for the ongoing…

Continue Reading

WednesdayNov 02, 2022 11:44 am

NetworkNewsBreaks – Industrial Nanotech Inc. (INTK) Issues Company Update

Industrial Nanotech (OTC: INTK), a global nanoscience solutions and research leader, today provided a company update. Among the highlights, the press release included a list of investor communications strategies the company is implementing as well as a brief status update on all announced deals and initiatives over the last 12 months. “Industrial Nanotech Inc. will no longer be outsourcing communications with our current and potential shareholders. The fact is that shareholders and I want the same two things: 1) the company to continue becoming more and more successful; 2) the stock price to accurately reflect those successes in increased shareholder…

Continue Reading

WednesdayNov 02, 2022 11:28 am

NetworkNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) Names New CFO

Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF), a clean-technology company developing transformative power conversion technologies and control system solutions for next-generation EVs and electrical systems, has announced a new chief financial officer. The company has appointed seasoned veteran Samuel Yik as CFO; he will take over the position on Nov. 23, 2022. A chartered professional accountant with a diverse business background, Yik has garnered more than two decades of experience in the public sector, with more than a decade serving as CFO and managing publicly listed U.S. and Canadian companies. Yik is replacing Raj Clair, who will be leaving the…

Continue Reading

WednesdayNov 02, 2022 10:35 am

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Eliminates Some $13M in Debt

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has eliminated $13 million in company debt, resulting in a reduction of overall indebtedness from more than $30 million last year to less than $10 million currently. The company has been working to strengthen its financial balance sheet; it also recently eliminated some $13 million of company debt associated with Esousa Holdings LLC. According to the announcement, MULN believes this debt conversion will save more than $3.5 million in interest expenses. With less than $10 million left of outstanding indebtedness, Mullen is maintaining its strong financial health. “It’s been a…

Continue Reading

WednesdayNov 02, 2022 10:22 am

NetworkNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Releases Financial Numbers for Q2

India Globalization Capital (NYSE American: IGC) is reporting financial results for second quarter 2023, the period ending Sept. 30, 2022. Highlights of the report include the potential shown by IGC-AD1 and TGR-63, the company’s main investigational drug assets, to suppress or ameliorate a key protein in Alzheimer’s cell lines that are responsible for Aβ plaques, a key indicator of Alzheimer’s disease. The company noted that IGC-AD1 is entering phase 2 trials designed to study the treatment of agitation in dementia resulting Alzheimer’s disease and, in preclinical trials, TGR-63 showed potential to reduce neurotoxicity in Alzheimer's cell lines. The report stated…

Continue Reading

TuesdayNov 01, 2022 2:16 pm

NetworkNewsBreaks – Florida Bitcoin & Blockchain Summit Opens Doors

The second annual Florida Bitcoin & Blockchain Summit (“FBBS”) is being held this week. The event, produced by Cutting Edge Events LLC, is scheduled for Nov. 4, 2022, in Tampa, Florida. Florida’s first blockchain-and-fintech-focused event, FBBS aims to make the state a leader in the blockchain and financial tech space. The event gathers key representatives from a broad spectrum of stakeholders, businesses, startups, political leaders, policymakers, regulators, fintech communities and evangelists. The gathering provides invaluable information for three types of participants: those new to crypto investing and fintech interested in increasing their industry knowledge; stakeholders, institutions or startups poised to…

Continue Reading

TuesdayNov 01, 2022 1:37 pm

NetworkNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Announces New Contracts, Indicative of Company’s Continued Reach

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has announced five new contracts. The contracts are with companies across the United States from several different industries. According to the announcement, the companies include an Ohio-based global pharmaceutical manufacturer and distributor of medical and laboratory products, as well as a provider of performance and data solutions for healthcare facilities; two hotels — one in Tennessee and one in Washington state; a sports complex in New York; and a multifamily housing complex in Pennsylvania. The contracts call for Knightscope ASRs to patrol and provide surveillance for everything from parking lots…

Continue Reading

TuesdayNov 01, 2022 1:24 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures IRB Approval for Human Clinical Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of independent review board (“IRB”) approval for human clinical nicotine study NIC-H22-1, and that human dosing will begin soon. The 36-person human pharmacokinetic (“pk”) randomized, double blinded, cross-over study will be conducted in current cigarette smokers, wherein each person will visit the laboratory to be dosed three times over a period of weeks. Only one oral nicotine pouch (either DehydraTECH-nicotine; On! brand manufactured by Altria; or Zyn brand manufactured by Swedish Match) will be administered during each visit and evaluated. Predetermined questionnaires for subjective…

Continue Reading

TuesdayNov 01, 2022 12:59 pm

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Exec to Present at Neuropsychiatric & Psychedelics Drug Development Summit

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), will be participating in the 5th annual Neuropsychiatric & Psychedelics Drug Development Summit. The summit runs through Nov. 2, 2022, and is being held in Boston. Cybin director of neuropharmacology Amy Reichelt, PhD, will present during the event; her presentation, titled “CYB004 — Modifications to DMT to Enhance its Therapeutic Potential,” includes an overview of the preclinical data for CYB004, Cybin’s deuterated dimethyltryptamine (DMT) program and the advantages of deuteration on its therapeutic effect. Reichelt’s presentation will begin at 1:15 p.m. ET today.“I am delighted to be…

Continue Reading